AXIS Large & Mid Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

AXIS Large & Mid Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

AXIS Large & Mid Cap Fund - Direct (G)

4.64%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

-

-

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

16469.27

1.79

38.02

October 1, 2018

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

13.5 %

15.8 %

4.64 %

14.01 %

19.35 %

7.4 %

Hitesh Das

PGDM, M.Tech, B.Tech

 Equity Research Analyst - Barclays Securities India Pvt. Ltd. (January 2012 - June 2015)  Equity Research Analyst - Credit Suisse Securities (India) Pvt. Ltd. (July 2011 - December 2012)  Equity Research Analyst - Ebusinessware (India) Pvt. Ltd. (February 2011 - June 2011)  Risk Analyst - Yes Bank (May 2010 - February 2011)

Jinesh Gopani

M.M.S in Finance from Mumbai University

He has total experience of 13 years in the capital markets of which 4 years are in equity fund management. Previous experience includes Birla Sun Life Mutual Fund and Voyager Capital.

Krishnaa N

Chartered Accountant and Bachelor of Commerce

Axis Asset Management Company Ltd [Fund Manager - (For Foreign Securities)] Period From - To March 01, 2024 till date Axis Asset Management Company Ltd (Junior Research Analyst - Equity) Period From - To May 12, 2021 - February 29, 2024 Price Waterhouse & Co LLP. Period From - April 22, 2019 - May 07, 2021

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right